cyc 202 has been researched along with flavokawain a in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (flavokawain a) | Trials (flavokawain a) | Recent Studies (post-2010) (flavokawain a) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 46 | 0 | 33 |
| Protein | Taxonomy | cyc 202 (IC50) | flavokawain a (IC50) |
|---|---|---|---|
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antheaume, C; Asakawa, Y; Barguil, Y; Guillaudeux, T; Herbette, G; Hnawia, E; Le Guével, R; Lebouvier, N; Nour, M; Thieury, C | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
1 review(s) available for cyc 202 and flavokawain a
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
1 other study(ies) available for cyc 202 and flavokawain a
| Article | Year |
|---|---|
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Cell Line; Cell Line, Tumor; Chalcone; Drug Screening Assays, Antitumor; Flavonoids; Humans; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2017 |